Search Videos and More
Video
Simmons Cancer Center Postdoctoral Program
Postdoctoral training at Simmons Cancer Center is a collaboration among UT Southwestern’s Graduate School of Biomedical Sciences, Medical School, and School of Health Professions. The program aims to enhance the careers of lab-based and clinical postdoctoral trainees and fellows through research training, clinical care experience, and mentorship.
Video
National Cancer Institute Redesignation
The National Cancer Institute has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation, reaffirming its place among the country’s elite cancer institutes.
News
PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients
UT Southwestern is leading research to find ways to extend the benefits of PARP-1 inhibitor maintenance medication to more patients with more forms of ovarian cancer.
News
Artificial Intelligence Algorithm Developed to Assess Metastatic Potential in Skin Cancers
Using artificial intelligence (AI), researchers from UT Southwestern have developed a way to accurately predict which skin cancers are highly metastatic.
News
The Consequences of Understaging Gastric Cancer
Patients with nonspecific symptoms that overlap with the symptoms of gastric cancers should be evaluated at a center with extensive experience in treating these cancers.
Video
CAR T-Cell Therapy Fights Cancer with a Live Weapon
By harnessing the full force of a patient's immune system, the targeted approach of CAR T-cell therapy makes it possible to mount a highly effective attack against certain cancers.
Video
Behind The Scenes: A Day in the Life of an Emergency Medicine Resident
What's it like to be an emergency medicine resident? Edmond (Eddie) Irankunda, MD, is a third-year resident in the University of Cincinnati Emergency Medicine Program, the first in the country.
News
Novel Biomarker Might Lead to Personalized, Targeted Therapy
ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients.